organization · Reporting owner

Camber Capital Management LP

Disclosed activity across 5 companies

Tapewire entity: 88462
SEC CIK: 0001444043

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AMAG PHARMACEUTICALS, INC.AMAG · Entity 145305	10% owner	October 01, 2020	October 05, 2020
ZimVie Inc.ZIMV · Entity 74112	10% owner	March 01, 2022	August 06, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMAG PHARMACEUTICALS, INC.

Report date October 01, 2020 · Filed October 05, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2020-10-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2020-10-01 · Sale · Disposed 4,390,000 · Balance 0 F1: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2: Of the securities reported for this transaction, 4,361,316 shares of Common Stock were sold for the account of the Master Fund and 28,684 shares of Common Stock were sold for the account of the Fund F3: As of the closing of trading on October 01, 2020, 0 shares of Common Stock were held for the account of the Master Fund and 0 shares of Common Stock were held for the account of the Fund.

Filing footnotes · ownership attribution and instrument terms

F1: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein.

F2: Of the securities reported for this transaction, 4,361,316 shares of Common Stock were sold for the account of the Master Fund and 28,684 shares of Common Stock were sold for the account of the Fund

F3: As of the closing of trading on October 01, 2020, 0 shares of Common Stock were held for the account of the Master Fund and 0 shares of Common Stock were held for the account of the Fund.

ZimVie Inc.

Report date March 01, 2022 · Filed August 06, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	2,725,000	Reported balance After 2024-08-02 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2024-08-02 · Sale · Disposed 525,000 · Balance 2,725,000 F1: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2: Of the securities reported for this transaction, 525,000 shares of Common Stock were sold for the account of the Master Fund F3: As of the closing of trading on August 02, 2024, 2,725,000 shares of Common Stock were held for the account of the Master Fund
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	2,725,000	Reported balance Holding disclosure · report date 2022-03-01 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 2,725,000 F4: The Reporting Person no longer beneficially owns more than 10% of the Issuer's common stock and is no longer subject to Section 16

Filing footnotes · ownership attribution and instrument terms

F1: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein.

F2: Of the securities reported for this transaction, 525,000 shares of Common Stock were sold for the account of the Master Fund

F3: As of the closing of trading on August 02, 2024, 2,725,000 shares of Common Stock were held for the account of the Master Fund

F4: The Reporting Person no longer beneficially owns more than 10% of the Issuer's common stock and is no longer subject to Section 16

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Cardiovascular Systems Inc

Report date September 19, 2016 · Filed September 21, 2016

Section 16 reporting ended · disclosed 2016-09-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	3,057,000	Reported balance After 2016-09-19 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2016-09-19 · Sale · Disposed 1,043,000 · Balance 3,057,000 F1: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2: Of the securities reported for this transaction, 1,012,462 shares of Common Stock were sold for the account of the Master Fund, 6,453 shares of Common Stock were sold for the account of the Fund, and 24,085 shares of Common Stock were sold for the account of the Managed Account.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	3,000,000	Reported balance After 2016-09-20 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2016-09-20 · Sale · Disposed 57,000 · Balance 3,000,000 F1: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F3: Of the securities reported for this transaction, 55,331 shares of Common Stock were sold for the account of the Master Fund, 353 shares of Common Stock were sold for the account of the Fund, and 1,316 shares of Common Stock were sold for the account of the Managed Account. F4: As of the closing of trading on September 20, 2016, 2,912,165 shares of Common Stock were held for the account of the Master Fund, 18,559 shares of Common Stock were held for the account of the Fund, and 69,276 shares of Common Stock were held for the account of the Managed Account.

Filing footnotes · ownership attribution and instrument terms

F1: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein.

F2: Of the securities reported for this transaction, 1,012,462 shares of Common Stock were sold for the account of the Master Fund, 6,453 shares of Common Stock were sold for the account of the Fund, and 24,085 shares of Common Stock were sold for the account of the Managed Account.

F3: Of the securities reported for this transaction, 55,331 shares of Common Stock were sold for the account of the Master Fund, 353 shares of Common Stock were sold for the account of the Fund, and 1,316 shares of Common Stock were sold for the account of the Managed Account.

F4: As of the closing of trading on September 20, 2016, 2,912,165 shares of Common Stock were held for the account of the Master Fund, 18,559 shares of Common Stock were held for the account of the Fund, and 69,276 shares of Common Stock were held for the account of the Managed Account.

ENDOLOGIX INC /DE/

Report date October 29, 2018 · Filed October 30, 2018

Section 16 reporting ended · disclosed 2018-10-30. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	9,300,000	Reported balance Holding disclosure · report date 2018-10-29 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 9,300,000 F1: Due to an increase in the number of outstanding shares of common stock of the Issuer, the Reporting Person no longer beneficially owns more than 10% of the Issuer's common stock and is no longer subject to Section 16

Filing footnotes · ownership attribution and instrument terms

F1: Due to an increase in the number of outstanding shares of common stock of the Issuer, the Reporting Person no longer beneficially owns more than 10% of the Issuer's common stock and is no longer subject to Section 16

Protalix BioTherapeutics, Inc.

Report date December 02, 2016 · Filed December 06, 2016

Section 16 reporting ended · disclosed 2016-12-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	10,775,000	Reported balance After 2016-12-02 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2016-12-02 · Sale · Disposed 2,500,000 · Balance 10,775,000 F1: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2: Of the securities reported for this transaction, 2,413,466 shares of Common Stock were sold for the account of the Master Fund, 16,998 shares of Common Stock were sold for the account of the Fund, and 69,536 shares of Common Stock were sold for the account of the Managed Account. F3: As of the closing of trading on December 06, 2016, 10,402,037 shares of Common Stock were held for the account of the Master Fund, 73,262 shares of Common Stock were held for the account of the Fund, and 299,701 shares of Common Stock were held for the account of the Managed Account.

Filing footnotes · ownership attribution and instrument terms

F2: Of the securities reported for this transaction, 2,413,466 shares of Common Stock were sold for the account of the Master Fund, 16,998 shares of Common Stock were sold for the account of the Fund, and 69,536 shares of Common Stock were sold for the account of the Managed Account.

F3: As of the closing of trading on December 06, 2016, 10,402,037 shares of Common Stock were held for the account of the Master Fund, 73,262 shares of Common Stock were held for the account of the Fund, and 299,701 shares of Common Stock were held for the account of the Managed Account.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 02, 2024 Filed Aug 6, 2024 16:15 UTC	ZimVie Inc. ZIMV · Entity 74112	SaleCommon Stock	525,000	$17.71	$9,299,377.50	Disclosure SEC source: 0001654954-24-010034 · section16.xml · nonDerivative · entry 1 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,725,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2 · ownership.nature: Of the securities reported for this transaction, 525,000 shares of Common Stock were sold for the account of the Master Fund F3 · ownership.nature: As of the closing of trading on August 02, 2024, 2,725,000 shares of Common Stock were held for the account of the Master Fund Read SEC document
October 01, 2020 Filed Oct 5, 2020 11:21 UTC	AMAG PHARMACEUTICALS, INC. AMAG · Entity 145305	SaleCommon Stock	4,390,000	$13.57	$59,586,787.00	Disclosure SEC source: 0001654954-20-010821 · section16.xml · nonDerivative · entry 1 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2 · ownership.nature: Of the securities reported for this transaction, 4,361,316 shares of Common Stock were sold for the account of the Master Fund and 28,684 shares of Common Stock were sold for the account of the Fund F3 · ownership.nature: As of the closing of trading on October 01, 2020, 0 shares of Common Stock were held for the account of the Master Fund and 0 shares of Common Stock were held for the account of the Fund. Read SEC document
August 09, 2019 Filed Aug 9, 2019 15:41 UTC	AMAG PHARMACEUTICALS, INC. AMAG · Entity 145305	PurchaseCommon Stock	3,400	$9.18	$31,205.54	Disclosure SEC source: 0001654954-19-009162 · section16.xml · nonDerivative · entry 5 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,390,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F6 · ownership.nature: Of the securities reported for this transaction, 3,378 shares of Common Stock were purchased for the account of the Master Fund and 22 shares of Common Stock were purchased for the account of the Fund F7 · ownership.nature: As of the closing of trading on August 09, 2019, 4,361,316 shares of Common Stock were held for the account of the Master Fund and 28,684 shares of Common Stock were held for the account of the Fund. Read SEC document
August 09, 2019 Filed Aug 9, 2019 15:41 UTC	AMAG PHARMACEUTICALS, INC. AMAG · Entity 145305	PurchaseCommon Stock	26,600	$8.94	$237,790.70	Disclosure SEC source: 0001654954-19-009162 · section16.xml · nonDerivative · entry 4 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,386,600 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F5 · ownership.nature: Of the securities reported for this transaction, 26,430 shares of Common Stock were purchased for the account of the Master Fund and 170 shares of Common Stock were purchased for the account of the Fund Read SEC document
August 07, 2019 Filed Aug 9, 2019 15:41 UTC	AMAG PHARMACEUTICALS, INC. AMAG · Entity 145305	PurchaseCommon Stock	4,000	$7.58	$30,300.00	Disclosure SEC source: 0001654954-19-009162 · section16.xml · nonDerivative · entry 3 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,360,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F4 · ownership.nature: Of the securities reported for this transaction, 3,974 shares of Common Stock were purchased for the account of the Master Fund and 26 shares of Common Stock were purchased for the account of the Fund Read SEC document
August 07, 2019 Filed Aug 9, 2019 15:41 UTC	AMAG PHARMACEUTICALS, INC. AMAG · Entity 145305	PurchaseCommon Stock	50,000	$7.74	$387,000.00	Disclosure SEC source: 0001654954-19-009162 · section16.xml · nonDerivative · entry 2 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,356,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F3 · ownership.nature: Of the securities reported for this transaction, 49,680 shares of Common Stock were purchased for the account of the Master Fund and 320 shares of Common Stock were purchased for the account of the Fund Read SEC document
August 07, 2019 Filed Aug 9, 2019 15:41 UTC	AMAG PHARMACEUTICALS, INC. AMAG · Entity 145305	PurchaseCommon Stock	301,000	$7.79	$2,343,495.70	Disclosure SEC source: 0001654954-19-009162 · section16.xml · nonDerivative · entry 1 Camber Capital Management LP · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,306,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2 · ownership.nature: Of the securities reported for this transaction, 299,074 shares of Common Stock were purchased for the account of the Master Fund and 1,926 shares of Common Stock were purchased for the account of the Fund Read SEC document
December 02, 2016 Filed Dec 6, 2016 20:26 UTC	Protalix BioTherapeutics, Inc. PLX · Entity 2671	SaleCommon Stock	2,500,000	$0.32	$792,000.00	Disclosure SEC source: 0001354488-16-008627 · issuerdirect_section16.xml · nonDerivative · entry 1 Camber Capital Management LLC · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 10,775,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2 · ownership.nature: Of the securities reported for this transaction, 2,413,466 shares of Common Stock were sold for the account of the Master Fund, 16,998 shares of Common Stock were sold for the account of the Fund, and 69,536 shares of Common Stock were sold for the account of the Managed Account. F3 · ownership.nature: As of the closing of trading on December 06, 2016, 10,402,037 shares of Common Stock were held for the account of the Master Fund, 73,262 shares of Common Stock were held for the account of the Fund, and 299,701 shares of Common Stock were held for the account of the Managed Account. Read SEC document
September 20, 2016 Filed Sep 21, 2016 12:28 UTC	Cardiovascular Systems Inc CSII · Entity 114141	SaleCommon Stock	57,000	$23.54	$1,341,643.20	Disclosure SEC source: 0001354488-16-008291 · issuerdirect_section16.xml · nonDerivative · entry 2 Camber Capital Management LLC · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,000,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F3 · ownership.nature: Of the securities reported for this transaction, 55,331 shares of Common Stock were sold for the account of the Master Fund, 353 shares of Common Stock were sold for the account of the Fund, and 1,316 shares of Common Stock were sold for the account of the Managed Account. F4 · ownership.nature: As of the closing of trading on September 20, 2016, 2,912,165 shares of Common Stock were held for the account of the Master Fund, 18,559 shares of Common Stock were held for the account of the Fund, and 69,276 shares of Common Stock were held for the account of the Managed Account. Read SEC document
September 19, 2016 Filed Sep 21, 2016 12:28 UTC	Cardiovascular Systems Inc CSII · Entity 114141	SaleCommon Stock	1,043,000	$23.25	$24,249,854.30	Disclosure SEC source: 0001354488-16-008291 · issuerdirect_section16.xml · nonDerivative · entry 1 Camber Capital Management LLC · CIK 0001444043 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,057,000 F1 · ownership.nature: Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund"), another private investment fund (the "Fund") and one managed account (the "Managed Account") for which the LLC serves as the investment manager. Stephen DuBois is the managing member of the LLC and managing member of the general partner for the Fund and the Master Fund. The LLC, the Master Fund, the Fund, the Managed Account, general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein. F2 · ownership.nature: Of the securities reported for this transaction, 1,012,462 shares of Common Stock were sold for the account of the Master Fund, 6,453 shares of Common Stock were sold for the account of the Fund, and 24,085 shares of Common Stock were sold for the account of the Managed Account. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.